BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33754019)

  • 21. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin.
    Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y
    J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin.
    de Sauvage FJ; Carver-Moore K; Luoh SM; Ryan A; Dowd M; Eaton DL; Moore MW
    J Exp Med; 1996 Feb; 183(2):651-6. PubMed ID: 8627177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF-1 facilitates thrombopoiesis primarily through Akt activation.
    Chen S; Hu M; Shen M; Wang S; Wang C; Chen F; Tang Y; Wang X; Zeng H; Chen M; Gao J; Wang F; Su Y; Xu Y; Wang J
    Blood; 2018 Jul; 132(2):210-222. PubMed ID: 29802222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Megakaryocyte growth factors.
    Williams N
    Immunol Ser; 1990; 49():215-29. PubMed ID: 2090252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual role of IL-21 in megakaryopoiesis and platelet homeostasis.
    Benbarche S; Strassel C; Angénieux C; Mallo L; Freund M; Gachet C; Lanza F; de la Salle H
    Haematologica; 2017 Apr; 102(4):637-646. PubMed ID: 28057742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
    Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
    Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs.
    Nishimura S; Nagasaki M; Kunishima S; Sawaguchi A; Sakata A; Sakaguchi H; Ohmori T; Manabe I; Italiano JE; Ryu T; Takayama N; Komuro I; Kadowaki T; Eto K; Nagai R
    J Cell Biol; 2015 May; 209(3):453-66. PubMed ID: 25963822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin- primitive progenitor cells.
    Young JC; Bruno E; Luens KM; Wu S; Backer M; Murray LJ
    Blood; 1996 Sep; 88(5):1619-31. PubMed ID: 8781417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cadmium Suppresses Bone Marrow Thrombopoietin Production and Impairs Megakaryocytopoiesis in Mice.
    Zhao Y; Zhang Y; He J; Zhai Y; Yang G; Xue P; Yao Y; He M; Qu W; Zhang Y
    Toxicol Sci; 2022 Mar; 186(2):309-322. PubMed ID: 35134237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.
    Broudy VC; Lin NL; Kaushansky K
    Blood; 1995 Apr; 85(7):1719-26. PubMed ID: 7535585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
    Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y
    Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
    Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS
    Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
    Drexler HG; Zaborski M; Quentmeier H
    Leukemia; 1997 Apr; 11(4):541-51. PubMed ID: 9096695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes.
    Schattner M; Lefebvre P; Mingolelli SS; Goolsby CL; Rademaker A; White JG; Foster D; Green D; Cohen I
    Stem Cells; 1996 Mar; 14(2):207-14. PubMed ID: 8991540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased megakaryocytopoiesis in Lyn-deficient mice.
    Lannutti BJ; Minear J; Blake N; Drachman JG
    Oncogene; 2006 Jun; 25(23):3316-24. PubMed ID: 16418722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression.
    Yang M; Li K; Chui CM; Yuen PM; Chan PK; Chuen CK; Li CK; Fok TF
    Br J Haematol; 2000 Oct; 111(1):371-80. PubMed ID: 11091227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
    Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
    Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of platelet factor 4 in radiation-induced thrombocytopenia.
    Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
    Deutsch VR; Tomer A
    Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.